[1] |
Zeng Y, Wu N, Zhang Z, et al. Non⁃coding RNA and arrhythmias: expression, function, and molecular mechanism[J]. Europace, 2023,25(4):1296⁃1308. doi: 10.1093/europace/euad047.
|
[2] |
Gu A, Jaijyan DK, Yang S, et al. Functions of circular RNA in human diseases and illnesses[J]. Noncoding RNA, 2023,9(4):38. doi: 10.3390/ncrna9040038.
|
[3] |
Singh S, Sinha T, Panda AC. Regulation of microRNA by circular RNA[J]. Wiley Interdiscip Rev RNA, 2023:e1820. doi: 10.1002/wrna.1820.
|
[4] |
Zhou M, Liu Y, Xu H, et al. YTHDC1⁃modified m6A methylation of hsa_circ_0102678 promotes keratinocyte inflammation induced by cutibacterium acnes biofilm through regulating miR⁃146a/TRAF6 and IRAK1 axis[J]. J Innate Immun, 2023,15(1):822⁃835. doi: 10.1159/000534704.
|
[5] |
Liang J, Wu X, Sun S, et al. Circular RNA expression profile analysis of severe acne by RNA⁃Seq and bioinformatics[J]. J Eur Acad Dermatol Venereol, 2018,32(11):1986⁃1992. doi: 10.1111/jdv.14948.
|
[6] |
Huang A, Zheng H, Wu Z, et al. Circular RNA⁃protein interactions: functions, mechanisms, and identification[J]. Theranostics, 2020,10(8):3503⁃3517. doi: 10.7150/thno.42174.
|
[7] |
Chen X, Zhou M, Yant L, et al. Circular RNA in disease: basic properties and biomedical relevance[J]. Wiley Interdiscip Rev RNA, 2022,13(6):e1723. doi: 10.1002/wrna.1723.
|
[8] |
Vishnoi A, Rani S. miRNA Biogenesis and regulation of diseases: an updated overview[J]. Methods Mol Biol, 2023,2595:1⁃12. doi: 10.1007/978⁃1⁃0716⁃2823⁃2_1.
|
[9] |
Zhao X, Zhong Y, Wang X, et al. Advances in circular RNA and its applications[J]. Int J Med Sci, 2022,19(6):975⁃985. doi: 10.7150/ijms.71840.
|
[10] |
Jin Z, Song Y, He L. A review of skin immune processes in acne[J]. Front Immunol, 2023,14:1324930. doi: 10.3389/fimmu.2023.1324930.
|
[11] |
Yang B, Wu Y, Chen Y, et al. MiR⁃5195⁃3p targets the PCBP2/PI3K/AKT pathway to inhibit melanoma cell proliferation and migration[J]. Heliyon, 2023,9(9):e19227. doi: 10.1016/j.heliyon.2023.e19227.
|
[12] |
Peng X, Zhao L, Yao L, et al. Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non⁃small cell lung carcinoma[J]. Thorac Cancer, 2023,14(19):1812⁃1823. doi: 10.1111/1759⁃7714.14926.
|
[13] |
Wang Z, Zhang X, Liu Y, et al. MiR⁃5195⁃3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer[J]. Histol Histopathol, 2023,38(12):1403⁃1413. doi: 10.14670/HH⁃18⁃595.
|
[14] |
Zeng X, Hu Z, Shen Y, et al. MiR⁃5195⁃3p functions as a tumor suppressor in prostate cancer via targeting CCNL1[J]. Cell Mol Biol Lett, 2022,27(1):25. doi: 10.1186/s11658⁃022⁃00326⁃8.
|